Kazuhisa Nishizawa

Title: Kazuhisa Nishizawa: Innovator in Protein Research

Introduction

Kazuhisa Nishizawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of protein research, particularly in the area of CD2 binding proteins. With a total of 3 patents, his work has implications for understanding cellular processes and potential therapeutic applications.

Latest Patents

Nishizawa's latest patents include the cloning and characterization of a CD2 binding protein known as CD2BP2. This patent describes a human CD2 cytoplasmic tail binding protein, along with the nucleic acids encoding the protein. It also details expression vectors and recombinant host cells that comprise nucleic acids encoding the CD2BP2 protein, as well as methods of use for both the protein and its encoding nucleic acids. Another significant patent involves the cloning and characterization of a CDC 15-like adaptor protein, referred to as CD2BP1. Similar to CD2BP2, this patent describes the nucleic acids encoding the CD2BP1 protein, expression vectors, recombinant host cells, and methods of use.

Career Highlights

Throughout his career, Kazuhisa Nishizawa has worked with esteemed institutions such as the Dana-Farber Cancer Institute and Harvard College. His research has been pivotal in advancing the understanding of protein interactions and their roles in cellular functions.

Collaborations

Nishizawa has collaborated with notable colleagues, including Ellis L Reinherz and Jing Li. These collaborations have further enriched his research and contributed to the scientific community's knowledge in the field.

Conclusion

Kazuhisa Nishizawa's innovative work in protein research, particularly with CD2 binding proteins, showcases his dedication to advancing scientific understanding. His contributions through patents and collaborations highlight the importance of research in developing potential therapeutic applications.